Source:http://linkedlifedata.com/resource/pubmed/id/17481771
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2007-10-1
|
pubmed:abstractText |
Twenty to forty percent of type-2 diabetic patients (DM2) present nephropathy. Genetic polymorphism of Apolipoprotein E (Apo E) has been proposed as a risk factor in the development and progression of diabetic nephropathy. The purpose of the study was to evaluate the relationship between Apo E polymorphism and presence of nephropathy in DM2 patients. We studied 85 DM2 patients with a similar nutritional state, environmental and socioeconomic condition and more than 10 years of evolution. They were grouped in DM2 patients with kidney complications (n=56) and without kidney complications (n=29; control group). Apo E genotype was determined by restriction fragment-length polymorphism analysis. A plasmatic biochemical characterization was performed on all the subjects studied. The 85 DM2 patients had arterial hypertension in treatment. The nephropathy diabetic group showed differences (p<0.001) in BMI, systolic blood pressure, glycemia, cholesterol (total, HDL and LDL), HbA1c and creatinine. The e4 allelic frequency was 8% in the nephropathy group versus 25.9% in the control group. Apo e3 allele and E3/3 genotype frequency were higher and E3/4 genotype was lower in the nephropathy group than in controls. These groups also showed differences in total, HDL and LDL cholesterol. DM2 patients without nephropathy presented a higher frequency of e4 allele. These results could suggest a protective role of e4 allele in the development and progression of diabetic nephropathy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0168-8227
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
196-201
|
pubmed:meshHeading |
pubmed-meshheading:17481771-Adult,
pubmed-meshheading:17481771-Aged,
pubmed-meshheading:17481771-Apolipoproteins E,
pubmed-meshheading:17481771-Cholesterol, LDL,
pubmed-meshheading:17481771-Diabetes Mellitus, Type 2,
pubmed-meshheading:17481771-Diabetic Nephropathies,
pubmed-meshheading:17481771-Female,
pubmed-meshheading:17481771-Gene Frequency,
pubmed-meshheading:17481771-Humans,
pubmed-meshheading:17481771-Hypercholesterolemia,
pubmed-meshheading:17481771-Male,
pubmed-meshheading:17481771-Middle Aged,
pubmed-meshheading:17481771-Polymorphism, Genetic
|
pubmed:year |
2007
|
pubmed:articleTitle |
Relationship between Apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients.
|
pubmed:affiliation |
Laboratorio de Bioquímica Clínica, Facultad de Ciencias de la Salud, Universidad de Talca, Talca, Chile. eleivam@utalca.cl
|
pubmed:publicationType |
Journal Article
|